The role of the serotonergic system in locomotor recovery after spinal cord injury by Mousumi Ghosh & Damien D. Pearse
NEURAL CIRCUITS
REVIEW ARTICLE
published: 09 February 2015
doi: 10.3389/fncir.2014.00151
The role of the serotonergic system in locomotor recovery
after spinal cord injury
Mousumi Ghosh1,2* and Damien D. Pearse1,2,3,4
1 The Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, FL, USA
2 Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, FL, USA
3 The Neuroscience Program, University of Miami Miller School of Medicine, Miami, FL, USA
4 The Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA
Edited by:
Hans Hultborn, University of
Copenhagen, Denmark
Reviewed by:
Deborah Baro, Georgia State
University, USA
Michael A. Lane, University of
Florida, USA
Hans Hultborn, University of
Copenhagen, Denmark
*Correspondence:
Mousumi Ghosh, The Miami Project
to Cure Paralysis and Department
of Neurological Surgery, University
of Miami Miller School of Medicine,
Lois Pope LIFE Center, P.O. Box
016960, Mail locator R-48, Miami,
FL 33101, USA
e-mail: mghosh@med.miami.edu
Serotonin (5-HT), a monoamine neurotransmitter synthesized in various populations
of brainstem neurons, plays an important role in modulating the activity of spinal
networks involved in vertebrate locomotion. Following spinal cord injury (SCI) there is a
disruption of descending serotonergic projections to spinal motor areas, which results
in a subsequent depletion in 5-HT, the dysregulation of 5-HT transporters as well as
the elevated expression, super-sensitivity and/or constitutive auto-activation of specific 5-
HT receptors. These changes in the serotonergic system can produce varying degrees
of locomotor dysfunction through to paralysis. To date, various approaches targeting
the different components of the serotonergic system have been employed to restore
limb coordination and improve locomotor function in experimental models of SCI. These
strategies have included pharmacological modulation of serotonergic receptors, through
the administration of specific 5-HT receptor agonists, or by elevating the 5-HT precursor
5-hydroxytryptophan, which produces a global activation of all classes of 5-HT receptors.
Stimulation of these receptors leads to the activation of the locomotor central pattern
generator (CPG) below the site of injury to facilitate or improve the quality and frequency of
movements, particularly when used in concert with the activation of other monoaminergic
systems or coupled with electrical stimulation. Another approach has been to employ
cell therapeutics to replace the loss of descending serotonergic input to the CPG, either
through transplanted fetal brainstem 5-HT neurons at the site of injury that can supply 5-HT
to below the level of the lesion or by other cell types to provide a substrate at the injury
site for encouraging serotonergic axon regrowth across the lesion to the caudal spinal cord
for restoring locomotion.
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INTRODUCTION
Spinal cord injury (SCI) is a devastating condition affecting
approximately 273,000 individuals in the US, with 12,000 new
cases occurring annually (National Spinal Cord Injury Statisti-
cal Center, University of Alabama, https://www.nscisc.uab.edu).
Damage to the spinal cord results in the impairment of specific
functions controlled by the nerves located at, or below, the level
of SCI. According to the presence or absence of motor func-
tion, human SCI can be classified as complete or incomplete.
Following incomplete injury, a certain degree of movement and
sensation below the level of injury may be retained depending
upon the severity of the injury and the corresponding extent
of axonal preservation. Complete SCI results in paralysis, due
to the lack of sensory and motor function below the level of
injury, though rarely is SCI anatomically complete in man. One
of the major consequences resulting from trauma to the spinal
cord is the disruption of the dynamic interactions among the
spinal neuronal network, supraspinal pathways and peripheral
sensory inputs, which results in an impairment of locomotor
function (Kiehn, 2006; Rossignol et al., 2006). This dysfunc-
tion is permanent due to the subsequent loss of motor neuron
excitability and the inability of the central nervous system (CNS)
to mount a robust reparative response endogenously. Although
the complete ablation of direct supraspinal projections to regions
below the injury results in the cessation of the voluntary control of
movements, some residual motor function may remain from the
spontaneous reorganization and recovery of neuronal network
excitability from plastic changes within any spared ascending and
descending systems (Ghosh et al., 2009; Tansey, 2010; Martinez
and Rossignol, 2011; Rossignol and Frigon, 2011; D’Amico et al.,
2014; El Manira, 2014; Filli et al., 2014).
To repair the injured spinal cord and restore voluntary motor
function various strategies have been employed. Among the dif-
ferent approaches used, those that have elicited the sprouting or
re-growth of serotonergic fibers caudal to the site of SCI have
often been associated with an ensuing improvement in locomotor
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function (Bregman et al., 2002; Engesser-Cesar et al., 2007). The
reactivation of the central pattern generator (CPG), an impor-
tant spinal cord center for locomotor output, and stimulation
of the locomotor neural network through (1) the exogenous
application of 5-HT (Cazalets et al., 1992; Madriaga et al., 2004;
Thompson et al., 2011) or its precursor, L-5-hydroxytryptophan
(5-HTP; Hayashi et al., 2010; Meehan et al., 2012); (2) through
the administration of agonists for specific serotonergic receptor
subsets, either alone (Antri et al., 2002; Landry and Guertin,
2004) or in combination with the stimulation of the dopaminergic
(DA) and the noradrenergic (NA) systems (Brustein and Rossig-
nol, 1999; Musienko et al., 2011) or; (3) the transplantation of
serotonergic embryonic neurons that can innervate these regions
(Privat et al., 1989; Rajaofetra et al., 1989a; Gimenez y Ribotta
et al., 1998), have provided convincing evidence in support of
an essential and indispensable role for the serotonergic system
in promoting the restoration of locomotor function after SCI.
Though it has been shown that concurrent stimulation of all
the monoaminergic systems, NA, DA and serotonergic (Jordan
et al., 2008), is important in the generation of locomotion, the
present review will focus specifically on the function of the
different components of the serotonergic pathway in regulating
motor function output with attention to how these components
are altered after SCI and lead to locomotor dysfunction. In
addition, the therapeutic modalities that have been employed
to modulate the serotonergic system in the CNS, in an attempt
to restore locomotor function after experimental SCI, are dis-
cussed.
5-HT AND ANATOMICAL LOCALIZATION OF ITS NEURAL
PATHWAYS
5-HT is a monoamine neurotransmitter synthesized from tryp-
tophan, an essential amino acid, by a subset of neurons referred
to as serotonergic neurons that are present in the CNS as well as
by enterochromaffin cells in the gastrointestinal tract (Li et al.,
2014). The anatomical localization of 5-HT pathways in the CNS
was initially delineated in the rat brain by Dahlstroem and Fuxe
(1964), who demonstrated that serotonergic neurons were largely
concentrated in the raphe nuclei of the brainstem. Almost all the
5-HT axons found within the mammalian spinal cord originate
supraspinally from neurons located in the brainstem (Takeuchi
et al., 1982), primarily from three main regions, the medullary
raphe pallidus, raphe obscuris and the raphe magnus (Azmitia,
1999), as well as part of the reticular formation that encompasses
the pyramidal tract at these levels. The 5-HT axon terminals orig-
inating from descending brainstem projections exist at all levels
of the spinal cord (Rajaofetra et al., 1989b; Hornung, 2003) and
are localized to the dorsal horn, ventral horn and intermediate
area (Ballion et al., 2002). Serotonergic projections innervating
the dorsal horn predominantly arise from the raphe magnus via
the dorsolateral funiculus, which also has sparse projections in
the ventral horn. The neurons in the raphe obscuris and pallidus
project to the ventrolateral white matter as well as terminate onto
motoneurons in the ventral horn and in the intermediate gray
via the ventral and ventrolateral funiculi, respectively (Azmitia
and Gannon, 1986). The axon collaterals from a single raphe
neuron are able to innervate both the sensory and motor nuclei
of the autonomic system at different spinal levels, including both
cervical and lumbar regions of the spinal cord (Martin et al.,
1981).
Previously, Rajaofetra et al. (1992a) demonstrated in adult
baboons that serotonergic innervation of the Onuf ’s nucleus,
located in the ventrolateral part of the sacral spinal cord, was of
both supraspinal and intraspinal origin. Supraspinal innervation
was found to exist throughout the whole nucleus, with a predom-
inance in the dorsal half, while the intraspinal innervation was
primarily associated with the ventral half of the nucleus. Subse-
quently, Branchereau et al. (2002) reported in organotypic spinal
cord cultures, which lacked descending serotonergic input, the
expression of 5-HT in intraspinal neurons; these 5-HT intraspinal
neurons were able to compensate for the lack of the descending
supraspinal 5-HT fibers and contribute to the development of
spontaneous locomotor activity. The 5-HT expressed by these
intraspinal neurons was dependent upon the absence of 5-HT
fibers as 5-HT from the descending input repressed expression
of 5-HT from these intraspinal neurons. In the human spinal
cord, Perrin et al. (2011) have mapped 5-HT profiles in the
thoracic and lumbar segments, finding a similar neuroanatom-
ical localization to that of rodents and non-human primates
where serotonergic processes were identified primarily within the
ventral horn surrounding motoneurons as well as also in the
intermediolateral region and in the superficial part of the dorsal
horn.
FUNCTION OF THE SEROTONERGIC PATHWAY IN
LOCOMOTION
Multiple descending tracts from the brainstem function in the
initiation and regulation of locomotion, including the gluta-
matergic, NA, DA and 5-HT pathways. These functions are medi-
ated through the action of various neurotransmitters such as
glutamate, NA, 5-HT and DA, which induce spinal motor activ-
ity, stimulate rhythmic activity and control segmental reflexes
(Humphreys and Whelan, 2012; Beliez et al., 2014; Sławin´ska
et al., 2014a). The role of 5-HT in locomotion remains, however,
only partially understood. Experimental work from a number
of research laboratories have provided convincing evidence that
5-HT regulates the rhythm and coordination of movements
through the CPG. The CPG constitutes a major anatomical com-
ponent of locomotion comprised of neurons distributed within
a neural network in the thoraco-lumbar spinal cord that drives
motoneuron output to generate simple rhythmic patterns, such
as locomotion (Grillner and Wallen´, 1985; Kiehn and Kullander,
2004). 5-HT has been recognized as a potent neuromodulator of
CPG activity (Feraboli-Lohnherr et al., 1997). The CPG in the
lumbar spinal cord is regulated both by supraspinal descending
inputs that originate in the raphe nucleus and terminate in the
intermediate gray and the ventral horn (Carlsson et al., 1963;
Ballion et al., 2002) as well as by sensory afferents (Rossignol et al.,
1988).
The neuronal network of the CPG, in response to monoamin-
ergic input from the brainstem, contributes to the regulation
of postural muscle tone and locomotion by determining which
components of the specific locomotor program are necessary at a
required or specific moment with respect to velocity, magnitude
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and duration (Takakusaki et al., 2004). Under normal conditions,
the different motor programs existing in the brainstem remain
in a state of inhibition during rest (Grillner, 2006; Hikosaka,
2007). Fornal et al. initially suggested that under these con-
ditions serotonergic neurons are controlled by tonic feedback
inhibition (Fornal et al., 1994). When locomotion is initiated,
signals activating the locomotor network in the mesencephalic
locomotor region (MLR) and the diencephalic locomotor region
(DLR) of the midbrain converge on reticulospinal neurons in the
brainstem, which determine the extent and duration of locomotor
activity that is necessary to be generated by the CPG. Therefore,
the MLR, when subjected to electrical or chemical stimulation,
triggers bouts of locomotion and elicits movement by activating
the reticulospinal pathways (Shik et al., 1966; Garcia-Rill et al.,
1985; Sholomenko and Steeves, 1987; Steeves et al., 1987). The
initial synaptic targets of the MLR are neurons in the medial
pontomedullary reticular formation (MdRF), after which their
axons descend as the reticulospinal tract within the ventrolateral
funiculus of the spinal cord to synapse on CPG neurons within the
cervical or lumbar segments (Steeves and Jordan, 1984; Garcia-
Rill et al., 1985; Noga et al., 1991).
As first discussed by Jacobs and Fornal (1993), the primary
function of 5-HT neurons in the brainstem is to facilitate motor
output during periods of tonic motor activity, such as postural
shifts, or to control repetitive motor behaviors that are mediated
by the spinal cord CPGs, such as locomotor speed. However, when
the spinal cord is injured, there can be significant disruption
or complete severing of the serotonergic projections, as well as
other descending systems, to the CPG and loss of locomotor out-
put. When exogenous 5-HT or selective 5-HT receptor agonists
are supplied systemically or intraspinally after SCI, in combina-
tion with sufficient excitation by epidural electrical stimulation
(EES) or glutamate, these locomotor behaviors can be re-elicited
(Schmidt and Jordan, 2000; Antri et al., 2002; Landry et al., 2006;
Courtine et al., 2009; Fouad et al., 2010).
5-HT participates directly in modulating motor function
output through its binding to specific 5-HT receptors present
upon the membrane of motoneurons. Depending on the spe-
cific receptor subtypes that are activated, either depolarization
or hyperpolarization of the motoneurons occurs—thus 5-HT
acts a control point in the regulation of spinal motoneuron
excitability, leading to an amplification of synaptic excitation or
inhibition (Perrier et al., 2013). Early studies employing selec-
tive 5-HT receptor agonists and antagonists provided evidence
that the activation of 5-HT1A receptors could mediate inhibitory
responses, whereas excitation was produced by the activation of
5-HT2A receptors (Bayliss et al., 1995). Excitatory neurotrans-
mission by 5-HT occurs through the modulation of various
ion channels which leads to a sustained depolarization due to
the presence of persistent inward currents that are mediated
by voltage sensitive Ca2+ and Na+ conductance to cause an
amplification of synaptic input. Following SCI, there is a reduced
input of brain stem-derived 5-HT which results in an altered
membrane potential of the motoneurons causing an acute sup-
pression of motoneuron excitability. This is attributed to various
factors such as motoneuron hyperpolarization coupled to an
acute disappearance of voltage-activated sodium and calcium
persistent inward currents which prevents activation of action
potentials. This inhibits motoneuron firing and increases pre-
synaptic inhibition thereby rendering the motoneuron and spinal
neuronal circuitry unexcitable acutely after the injury. 5-HT
can also modulate motoneuron excitability indirectly through its
effects on spinal interneurons where 5-HT can alter the action
potential properties of these interneurons, especially following
SCI. It has been observed in mouse lumbar V2a spinal interneu-
rons (Husch et al., 2012) that an enhanced 5-HT super sensitivity
occurs after SCI due to the elevated density of 5-HT2C receptors
on the cell membrane without promoting any significant changes
in their level of excitability. 5-HT thus participates in regulating
the firing frequency and excitability of spinal motor neurons,
which corresponds to its ability to control the speed and ampli-
tude of locomotion as well as alter the membrane properties of
spinal interneurons (Harris-Warrick and Cohen, 1985; Zhang and
Grillner, 2000; D’Amico et al., 2014; Wienecke et al., 2014) to
promote increased motoneuron excitability. SCI-induced losses of
5-HT, however, can lead not only to an absence of motoneuron
excitability and locomotor output but residual 5-HT or activity of
its receptors may also produce aberrant motoneuron excitability
that is involved in triggering spasticity and/or impaired motor
output that can hinder normal locomotion (Perrier et al., 2013).
This is an outcome observed following chronic SCI, where per-
sistent inward currents are enhanced either due to compensatory
over-expression of spontaneously active 5-HT2 receptors (Murray
et al., 2010) or as a result from a depolarized chloride reversal
potential (Boulenguez et al., 2010).
5-HT RECEPTOR ACTIVATION AND LOCOMOTION
The different members of the 5-HT family of receptors are
located within distinct areas of the central and the peripheral
nervous systems, as well as in non-neuronal tissues, and are
involved in a diversity of functions. The 5-HT receptor fam-
ily represents one of the most complex families of neurotrans-
mitter receptors that have been characterized to date. Studies
conducted by a number of research groups have provided con-
vincing experimental evidence that the descending serotonergic
system modulates spinal reflexes and motor function/hind limb
coordination through the activation of specific 5-HT receptors,
which in turn cause an increase in motoneuron and interneuron
excitability and the generation of CPG-mediated locomotor out-
put (Schmidt and Jordan, 2000; Hochman et al., 2001; Pflieger
et al., 2002).
A number of 5-HT receptor subtypes are expressed in high
density on the membranes of motoneurons, including 5-HT1A,
5-HT1B, 5-HT1D, 5-HT2A, 5-HT2B, 5-HT2C and 5-HT5A (Perrier
et al., 2013) as well as some spliced variants, 5-HT3, 5-HT4, 5-
HT6, 5-HT7 and RNA edited isoforms, such as 5-HT2C (Werry
et al., 2008). These receptors mostly exist as homodimers,
although they may also undergo heterodimerization (Renner
et al., 2012). Dimerization occurs during their biosynthesis within
the endoplasmic reticulum, which is important for their sub-
sequent transport and expression in the plasma membrane as
well as maximizes downstream coupling with the G-protein sub-
units (Herrick-Davis, 2013) that leads to motoneuron excitability.
Delineating the signaling mechanisms regulated by 5-HT has been
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difficult due to both the existence of multiple 5-HT receptor
isoforms that are activated in the presence of 5-HT as well as
the unavailability of highly selective pharmacological modulators
that can act on single receptor subtypes. In the human brain,
13 5-HT GPCRs and one serotonin-gated ion channel receptor,
5-HT3, have been identified (Millan et al., 2008; Lambe et al.,
2011). Though 5-HT receptors have been classified under seven
known subfamilies, 5-HT1 through 5-HT7, post-genomic mod-
ifications, such as alternative mRNA splicing or mRNA edit-
ing, have resulted in the identification of at least 30 distinct
5-HT receptor subtypes (Raymond et al., 2001). It has been
demonstrated that the combined activation of more than one
5-HT receptor subtype is required for the generation of loco-
motor output, with signaling originating primarily from 5-HT1A,
5-HT2A/C and 5-HT7 receptor subtypes (Jordan et al., 2008).
Work to date in characterizing 5-HT receptor activation involve-
ment in real or fictive locomotor output have focused largely
on motoneurons, as they are the direct effecters of locomotor
activity, in addition to the spinal interneurons that comprise the
CPG.
With the availability of agonists and antagonists that exhibit
greater selectivity for specific 5-HT receptor subtypes, studies
have begun to identify which 5-HT receptor subtypes medi-
ate specific locomotor behaviors. Employing receptor-specific
agonists and antagonists, which have varying binding affinities
towards each of the 5-HT receptor subsets, researchers have
identified 5-HT1A, 5-HT2A/2C (Courtine et al., 2009), 5-HT3
(Guertin and Steuer, 2005), and 5-HT7 receptors (Liu et al., 2009)
as important players in the regulation of the spinal locomotor
network and which are able to generate locomotion in experi-
mental models of SCI when employed in conjunction with the
activation of other monoaminergic systems (Kim et al., 2001a;
Antri et al., 2003; Fuller et al., 2005; Madriaga et al., 2004;
Guertin and Steuer, 2005; Ung et al., 2008; Courtine et al.,
2009; Liu et al., 2009; Musienko et al., 2011). Studies employing
5-HT receptor selective agonists and antagonists in rats follow-
ing spinal transection have identified that 5-HT2 receptors are
predominantly responsible for mediating the depolarizing effects
resulting from decreased potassium conductance in response to
a 5-HT stimulus (Jacobs and Fornal, 1993; Harvey et al., 2006;
Li et al., 2007; Perrier et al., 2013; Gackière and Vinay, 2014). In
experiments carried out by Ung et al. (2008), in which behavioral
and kinematic analyses were performed at 1 week after complete
spinal cord transection in mice, they identified the involvement
of specific 5-HT2 receptor subtypes in locomotor-like movements
through the use of selective antagonists. The non-selective 5-HT2
receptor agonist quipazine was able to induce locomotor-like
movements in the presence of the selective 5-HT2 antagonists
SB204741 and SB242084, which are inhibitory towards 5-HT2B
or 5-HT2C, respectively. In contrast, quipazine failed to induce
locomotor-like movements in animals that had been pretreated
with MDL-100,907, a selective 5-HT2A antagonist. This work
provided evidence that 5-HT2A receptors were involved in spinal
locomotor network activation and the generation of locomotor-
like movements induced by quipazine in transected animals. Antri
et al. (2003) showed that the combined, daily stimulation of
5-HT2 and 5-HT1A receptors, using quipazine and 8-OHDPAT,
respectively, after thoracic spinal cord transection in rats was
more potent in restoring locomotion then when the 5-HT2
agonist was employed alone, suggesting a cumulative effect of
activating the two receptor subtypes in facilitating locomotion.
5-HT1A receptors are localized throughout the CNS with high
expression in limbic regions and in the dorsal raphe nucleus,
while in the spinal cord, 5-HT1A receptors are identified primarily
within the ventral horn surrounding motoneurons, although 5-
HT1A receptors are more densely expressed at the lumbar level
of the spinal cord. 5HT1A receptors have been shown to produce
hyperpolarization preferentially in a small subset of neurons,
such as CA1 hippocampal neurons (Bobker and Williams, 1990;
Levkovitz and Segal, 1997) and interneurons (Segal, 1990a,b).
Therefore depending upon the specific receptor that 5-HT binds
to, it can elicit either depolarizing or hyperpolarizing effects.
CAUDAL SEROTONERGIC AXON INNERVATION AND 5-HT
LEVELS AFTER SCI AND THEIR EFFECTS ON RECOVERY
With 5-HT release within the spinal cord ventral horn playing a
major role in mediating locomotor function, it is not surprising
that following SCI, when there is severing of supraspinal seroton-
ergic projections and depletion of 5-HT (Carlsson et al., 1963),
that loss of 5-HT is one of the major limiting factors that prevents
the recovery of motor function (Hashimoto and Fukuda, 1991).
5-HT loss after SCI is characterized by significant reductions or
an absence of important enzymes such as tryptophan hydroxy-
lase (TPH), which catalyzes the conversion of tryptophan to 5-
hydroxytryptophan (5-HTP), that are necessary to generate 5-HT
(Clineschmidt et al., 1971). Loss of 5-HT prevents the activation
of the spinal locomotor CPG, interfering with the ability to evoke
normal locomotion. When 5-HT levels are restored, locomotor
function after SCI has been shown to be improved (Pearlstein
et al., 2005).
Previous work by Hentall et al. (2006) characterized the spatial
and temporal patterns of 5-HT release in the rodent lumbar spinal
cord following electrical stimulation of the raphe magnus in SCI
rats subjected to acute spinal cord transection at T6–T7. Their
findings indicated that the action of monoamines in the spinal
cord involves a combination of both synaptic neurotransmis-
sion as well as non-synaptic diffusion, similar to that previously
observed (Bach-y-Rita, 1999). Noga et al. (2004) employed fast
cyclic voltammetry, capable of measuring monoamines such as
5-HT at high spatial resolution in comparison to microdialysis-
HPLC, to map the basal and steady-state extracellular distribution
of monoamines released from tonically active, descending nerve
terminals in the lumbar spinal cord of rats when at rest and
after spinal cord transection. Their results demonstrated that
at rest there was a greater concentration of 5-HT localized in
specific regions of the dorsal and ventral horn of the lumbar
cord as well as in the lateral region of the intermediate zone
which varied within the different segments of the lumbar cord.
Following thoracic spinal cord transection, a transient injury
evoked increase in monoamine levels was noted briefly acutely
within the distal stump of the transected cord. Maximal levels
were measured in the superficial dorsal horn of the lumbar
cord during this transient period after which there was a steady
longer lasting decrease in monoamine levels (Noga et al., 2004).
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Recently, Gerin et al. (2010) examined temporal alterations in
the level of endogenous 5-HT release in the ventral horn of rats
that were subjected to a sub-hemi-section of the spinal cord
at the T9 vertebral level. Release of 5-HT was measured using
a microdialysis probe and HPLC analysis, with results showing
variations in the levels after SCI over a period of a month during
the post-injury recovery period as well when the injured animals
were subjected to treadmill exercise. It was found that a significant
decrease in 5-HT levels occurred after SCI, which was <50% of
that observed in non-lesioned animals, indicative of serotonergic
denervation. With time post-SCI, 5-HT levels were found to rise,
increasing by 202% at 18 days post injury compared to the levels
observed at 8 days post-lesion, which correlated with the timing of
motor function recovery. When treadmill exercise was performed,
a∼10% decrease in 5-HT levels was observed compared to rest at
18 and 34 days post-SCI.
ALTERATIONS IN 5-HT RECEPTOR ACTIVITY AFTER SCI
Previous studies using a complete spinal transection in the cat
have shown that SCI leads to an immediate and dramatic reduc-
tion in motoneuron excitability (Hounsgaard et al., 1988; Miller
et al., 1996). Spinal cord contusion in rodents, an incomplete SCI
paradigm that is more clinically-relevant, leads to the preserva-
tion of a small number of serotonergic fibers that can undergo
sprouting with time following an injury. The degree of locomo-
tor function restoration observed after SCI has been reported
to correlate to the density of sprouting of residual, uninjured
serotonergic axons (Holmes et al., 2005; Nardone et al., 2014).
The use of 5-HT receptor agonists in animals after an acute spinal
transection has been shown to produce restoration of motoneu-
ron excitability (Harvey et al., 2006; Li et al., 2007; Musienko et al.,
2011; Sławin´ska et al., 2014a). Work by various researchers have
demonstrated that locomotor-activated spinal neurons, which
constitute the CPG network, are innervated by serotonergic fibers
(Johnson et al., 2002; Perrin et al., 2011; Sławin´ska et al., 2014b)
and that 5-HT is released within these sites during locomotor
activity (Gerin et al., 2008). Together, these results have shown
that serotonergic innervation and the availability of 5-HT in the
lumbar cord (Antri et al., 2002) are critical for the restoration of
hind limb motor function following SCI.
The loss of 5-HT can be overcome through the direct activa-
tion of 5-HT receptors, an approach which has been convincingly
associated with the induction of locomotor output following
SCI (Brustein and Rossignol, 1999; Feraboli-Lohnherr et al.,
1999; Kim et al., 2001b). With the reduction or loss of 5-HT
input caudal to the injury in rodent models of SCI, it has been
demonstrated that there is a compensatory over-expression of
5-HT receptors (Fuller et al., 2005; Navarrett et al., 2012; Ren
et al., 2013). In the lamprey, a vertebrate that exhibits locomotor
recovery after complete SCI, a transient over-expression of the
5-HT1A receptor transcript is observed for several weeks after
SCI (Cornide-Petronio et al., 2014). In rats, Kong et al. (2010)
reported a dramatic increase in 5-HT2A receptor immunoreactiv-
ity in motoneurons caudal to the site of spinal cord transection,
beginning 1 day after injury and persisting to maximal expression
by 28 days which paralleled a concurrent reduction in the levels of
5-HT and the 5-HT transporter (Kong et al., 2011; Husch et al.,
2012). Work by Otoshi et al. (2009) examined the influence of
descending serotonergic input and sensory feedback on spinal
5-HT receptor expression using two paradigms. The first was a
complete thoracic (T7–T8) spinal cord transection in adult rats,
to eliminate supraspinal 5-HT input, while the second employed
animals subjected to spinal cord isolation, so as to completely
ablate both descending supraspinal as well as peripheral sensory
input, completely eliminating any neuromuscular activity. They
found that there was an enhanced expression of the 5-HT1A
receptor after transection that was dependent upon the presence
of sensory input.
Murray et al. (2010) have provided findings that may explain
how motoneurons are able to mediate some residual hind limb
function in rodent models of complete spinal cord transection
(S2, sacral spinal level) or with staggered hemisection, both of
which remove the descending supraspinal projections caudal to
the level of SCI. It appears that this residual function can arise as
a result of alterations in 5-HT receptor expression and their con-
stitutive activation as a compensatory mechanism. A SCI-induced
alteration in the levels of the 5-HT2C receptor has been correlated
to a change the post-transcriptional editing of its mRNA that
results in both elevated production and constitutive activation.
SCI-mediated constitutive activation of 5-HT2C receptors is able
to restore large persistent calcium currents in motoneurons,
which in turn is able to induce sustained muscle contractions
and the restoration of motor function. Therefore, despite the
non-availability of a serotonergic stimulus following SCI, which
results in loss of motoneuron excitability acutely, a compensatory
upregulation of spontaneously active 5-HT2 receptors induced at
chronic stages after SCI appears to be an adaptive mechanism
which could be responsible for residual locomotor function.
The use of EES, applied onto the dorsal surface of the lumbar
spinal cord or given intraspinally, has been used in decerebrated
and acute spinal cord transected cats (Iwahara et al., 1992;
Gerasimenko et al., 2007) as well as in rats (Ichiyama et al., 2005)
to activate the spinal locomotor circuits so as to induce hind limb
movements and locomotion (Gerasimenko et al., 2007; Courtine
et al., 2009). The use of EES in SCI patients, to promote locomotor
function, was first employed by Dimitrijevic et al. (1998), later
optimized in paralyzed individuals in work by Shapkova et al.
(Shapkova and Schomburg, 2001; Shapkova and Mushkin, 2002;
Shapkova, 2004) and is currently being evaluated in clinics in the
US (Harkema et al., 2011). Recently, Angeli et al. (2014) suc-
cessfully used epidural stimulation to activate spinal circuitry in
completely paralyzed American Spinal Injury Association Impair-
ment Scale (AIS) A patients, opening a new avenue for therapeutic
interventions to promote functional recovery after SCI. Through
the use of immunohistochemistry, Noga et al. (2009) showed the
co-localization of serotonergic axons with specific 5-HT receptor
subtypes 5-HT1A, 5-HT2A and 5-HT7, on c-Fos immunoreactive
neurons within laminae VII and VIII of the thoraco-lumbar
spinal cord segments following EES in pancuronium-paralyzed,
decerebrate cats. The presence of these 5-HT receptor subtypes
on these spinal neurons in T13–L7 spinal cord indicates that they
likely play a role in 5-HT’s modulation of locomotion.
To assess the roles of the specific 5-HT receptor subtypes
after SCI that have been identified to be involved in locomotor
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output function; 5-HT1A (Courtine et al., 2009), 5-HT2A/2C
(Courtine et al., 2009), 5-HT3 (Guertin and Steuer, 2005) and
5-HT7 (Liu et al., 2009), Musienko et al. (2011) conducted
experiments using pharmacological manipulations with combi-
nations of receptor specific agonists and/or antagonists. These
studies were performed in adult rats subjected to a complete
spinal cord transection at the mid-thoracic vertebral level (T7)
and the effects of receptor manipulations on observed func-
tional recordings were analyzed during locomotion enabled by
EES. From these studies, specific functional roles for each of
the 5-HT receptors in modulating motor function output were
identified. It was shown that when transected animals were pre-
treated with the 5-HT7 specific antagonist SB269970, prior to
the administration of 8-OHDPAT, a dual agonist for 5-HT1A/7,
and used in conjunction with EES, a marked improvement in
the animal’s stepping patterns and inter-limb coordination was
observed along with a reduction in kinematic variability and an
increase in weight-bearing capacity. These improvements were
not seen when EES was used alone, demonstrating an essen-
tial role of 5-HT1A receptors in facilitating locomotion, as also
reported by other groups (Antri et al., 2003; Courtine et al.,
2009). Similarly, they observed that activation of 5-HT2A/C recep-
tors with the general 5-HT2 receptor agonist quipazine, in the
presence of EES, produced facilitation of extension of the distal
joints along with an improvement in weight-bearing capacity
that was not observed with EES alone. When the 5-HT3 receptor
agonist SR57227A was used with EES, the animals exhibited
both an enhancement in weight-bearing as well as a reduction
in gait timing variability and paw dragging. The combined acti-
vation of 5-HT7 and 5-HT1A receptors with EES also elicited
an improvement in stepping pattern and produced a potent
facilitation in joint flexion, while combined activation of 5-
HT7 and 5-HT2A/C receptors improved inter-limb coordination,
reduced the duration of dragging and substantially increased
weight bearing capacity. Finally, the simultaneous activation of
all four receptor subtypes, 5-HT1A, 5-HT2A/C and 5-HT7, with
EES led to a significant increase in the EMG activity of the
proximal extensor and flexor muscles compared with the stepping
pattern elicited by EES alone. These results suggest that it may
be necessary to target multiple 5-HT receptors in combination
to obtain maximal efficacy in overall locomotor output in the
presence of EES (Musienko et al., 2011), although it remains to
be tested whether altering the sequential stimulation of different
receptor subtypes will be needed to obtain optimal locomotor
output.
In addition to pharmacological modification of specific 5-HT
receptor subtypes, more recent work has focused on the use of
molecular tools to examine receptor function using knockout
approaches in transgenic animals. In mice lacking the 5-HT1A
receptor, work by Scullion et al. (2013) confirmed the impor-
tant role of 5-HT1A receptors in the generation of locomotion.
5-HT1A knockout mice showed higher movement thresholds and
smaller motor maps compared with wild-type animals. Increased
use of transgenic animals, particularly conditional knockouts, to
study the role of specific receptor subtypes in the spinal cord
should be undertaken to provide a more specific approach than
pharmacological agents for dissecting the function different 5-HT
receptors play in the generation of motor output, both under
normal locomotion and in the context of locomotor recovery
following SCI.
DIFFERENTIAL ACTIVITY OF 5-HT RECEPTOR SUBTYPES IN
INDUCING LOCOMOTION AFTER SCI
Although 5-HT acts on its multiple receptor subtypes, it can trig-
ger different signaling pathways that may have excitatory (Cazalets
et al., 1992; MacLean et al., 1998) or inhibitory (Schmidt and
Jordan, 2000) effects on motor output. Depending on which 5-
HT receptors are expressed and activated as well as their cellular
and/or specific regional localization within the injured spinal
cord, the serotonergic system can produce differential effects on
locomotion (Landry et al., 2006; Courtine et al., 2009). Such
a variation in response has been noted in phrenic motoneu-
rons where 5-HT displays a differential effect elicited by the
5-HT1B and 5-HT2A receptor subtypes, where by one acts in
a stimulatory capacity and the other is inhibitory (Holtmanj
et al., 1986; Lalley, 1986). Work by Di Pasquale et al. (1997)
showed that while 5-HT2A activation mediated neuronal depo-
larization of phrenic motoneurons, pharmacological activation
of the 5-HT1B receptor resulted in the opposite effect, with
inhibition of phrenic activity. This inhibition could be prevented
by pre-treatment with 5-HT1B receptor specific antagonists, indi-
cating that opposite effects could be evoked in response to the
activation of these two receptor subtypes. Thus 5-HT is able
to regulate phrenic motoneuron firing via activation of spinal
postsynaptic 5-HT2A and presynaptic 5-HT1B receptors, which
in turn function to protect the diaphragm from overstimulation
during a non-respiratory action such as vomiting or defecation.
Similar differential effects of 5-HT elicited by different 5-HT
receptor subtypes have also been demonstrated in spinalized
rats, where monosynaptic transmission is inhibited or stimu-
lated with the activation of 5-HT1A and 5-HT2A/2C receptors,
respectively (Hasegawa and Ono, 1996). Using specific agonists
for 5-HT1 and 5-HT2 receptor subtypes, differential effects on
hind limb locomotor activity in adult mice after complete tho-
racic spinal cord transection were reported (Landry and Guertin,
2004). While 5-HT2A/2C receptor agonists facilitated locomotion,
stimulating 5-HT2B/2C or 5-HT1B receptors not only failed to
induce locomotor-like movements, but also abated the hind limb
movements induced by the non-specific 5-HT receptor agonist
quipazine, when combined with L-DOPA. The involvement of
5-HT2 receptors in mediating excitation has also been shown
in the completely transected cat spinal cord where restoration
of extensor reflex excitability could be achieved only with 5-
HT2A/2C specific agonists in contrast to 5-HT1A and 5-HT1B/D
receptors, which were determined to be ineffective (Miller et al.,
1996).
SERTs AND LOCOMOTION AFTER SCI
Neurotransmission between two or more cell types occurs pri-
marily through volume or synaptic transmission where, with
the former, the point of release of the neurotransmitter might
be at a distant location from that of the target cells. Vol-
ume transmission is associated with nonsynaptic interneuronal
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communication involving a widespread activation of extrasy-
naptic as well as intrasynaptic receptors (Agnati et al., 1986).
This produces a longer duration in the transmission of the
signal and requires the diffusion of the neurotransmitter. In
comparison, synaptic transmission occurs within a relatively
constrained region of the synaptic cleft, between the pre- and
the post-synaptic neurons. The duration of 5-HT signaling is
regulated by the function of two types of transporters. The
vesicular monoamine transporter (VMAT) which pumps 5-HT
from the cytoplasm into synaptic vesicles and thereby controls
the release of 5-HT from the presynaptic neurons. The other is
the serotonin re-uptake transporter (SERT) which exists in the
presynaptic plasma membrane of the serotonergic neurons and
re-absorbs extracellular 5-HT back into the cytoplasm (Iversen,
1971; Blakely et al., 1991; Rudnick and Clark, 1993; Torres et al.,
2003; Murphy et al., 2004) resulting in termination of 5-HT
neurotransmission and preventing extrasynaptic transmission
(Blakely et al., 1991; Schloss et al., 1992; Lesch et al., 1993).
The regulation of serotonergic signaling by SERTs plays a key
role in the regulation and the functioning of the serotoner-
gic system in locomotion (Hayashi et al., 2010; Husch et al.,
2012).
Various allosteric modulators of SERTs are currently gaining
significant clinical importance as a way to enhance the functional
capacity of these transport proteins when concentrations of 5-
HT are rate limiting, such as observed following SCI. Work
conducted by Hayashi et al. (2010) has suggested that even if
5-HT receptors are up-regulated following spinal cord transec-
tion and are thus available for the generation of locomotion
when activated by specific agonists, the same approach may not
be as effective in improving locomotor function in incomplete
SCI models, such as a spinal cord contusion. Though spared
supraspinal serotonergic projections are retained after incomplete
SCI, there appears to be an absence of 5-HT receptor activation,
despite an enhanced upregulation of 5-HT2C receptors caudal to
the injury. It was shown in this study that the administration of
selective 5-HT2C or 5-HT1A receptor agonists, either alone or in
combination after contusive SCI, was unable to produce receptor
activation as evidenced from a lack of improvement in hind limb
motor function. An improvement in motor function was only
observed when there was broad receptor activation produced by
the administration of the 5-HT precursor, 5-hydroxytryptophan
(L-5-HTP), suggesting that an elevation in the levels of sero-
tonergic receptors alone may not be sufficient to promote an
improvement in motor function in models of incomplete injury.
Even though there are spared serotonergic axons that are retained
after contusive SCI, it has been suggested that they may have
impaired function due to a dramatic reduction in the levels of
SERTs, resulting in a dysregulation of 5-HT reuptake (Husch et al.,
2012). Therefore prominent loss of SERT may be the causative
reason for a reduced ability of the 5-HT agonists to improve
locomotor outcome after an incomplete injury, indicating SERT
as a critical limiting factor that is necessary to overcome loco-
motor impairment following SCI. Work to transgenetically over-
express SERTs in animals receiving SCI and the administration
of selective 5-HT1 and 5-HT2 agonists would provide strong
evidence for a role of SERTs in both SCI-mediated locomotor
dysfunction and as a therapeutic modality for facilitating loco-
motor output.
TRANSPLANTATION PARADIGMS INVOLVING THE DELIVERY
OF 5-HT EXPRESSING CELLS TO IMPROVE LOCOMOTOR
OUTCOME AFTER SCI
Although a number of pharmacological approaches have been
employed to activate the CPG to induce locomotion in models
of SCI with varying degrees of success as described above, an
alternative has been to introduce cells into the injured spinal
cord that are capable of producing 5-HT. These exogenous 5-HT
expressing cells can be used to replace the loss of monoaminergic
supraspinal afferents and serve as a relay to restore serotonergic
projections caudal to the level of the injury (Bregman, 1994).
One such cell type that has been employed for this purpose
is embryonic brainstem neurons or raphe neurons, which are
able to extend serotonergic axons into adjacent host spinal tis-
sue to deliver 5-HT following transplantation at, or below, the
level of the injury (Privat et al., 1989; Rajaofetra et al., 1989a,
1992b; Gimenez y Ribotta et al., 1998; Ribotta et al., 2000).
The intraspinal transplantation of these cells has been shown
to reverse SCI-induced changes in 5-HT receptor densities and
to restore hind limb weight support and locomotor activity on
a treadmill, without the need for additional pharmacological
interventions (Gimenez y Ribotta et al., 1996). Studies carried out
by Feraboli-Lohnherr et al. (1997), employing the transplantation
of embryonic brainstem neurons within the transected thoracic
cord of chronically injured rats, showed that these neurons were
able to provide serotonergic innervation to the lumbar cord. The
projections from the transplanted brainstem neurons successfully
activated the CPG to facilitate locomotor activity and this effect
was further improved when a 5-HT re-uptake inhibitor was intro-
duced. Majczyn´ski et al. (2005) performed grafting of embryonic
raphe nuclei cells into the spinal cord at T12, below the level of
a complete spinal cord transection at T9 in adult rats at 1 month
post injury and showed that hind limb locomotor function could
be restored. The transected animals receiving the cell grafts, when
placed on a treadmill, were able to walk with regular, alternating
hind limb movements and exhibited plantar contact with the
ground during the stance phase as well as ankle dorsiflexion
during the swing phase of each step cycle. These behaviors were
not observed in the injured control animals that did not receive
the grafts and reflected the establishment of new serotonergic
innervation to the caudal cord by the grafted neurons. The
observed improvement in locomotor activity with embryonic
raphe nuclei cell grafts could be reduced in the presence of the 5-
HT2 antagonist cyproheptadine, and the loss of function regained
with the 5-HT2 agonist quipazine, suggesting a 5-HT2 receptor
mediated effect.
A similar improvement in locomotor performance was
observed when embryonic raphe cells were transplanted into
the spinal cord of chronically injured rats that had received a
transection SCI at either T9 or T11 (Gimenez y Ribotta et al.,
1996). The degree of locomotor recovery correlated to the level at
which the SCI or the transplant were made, with a better outcome
observed when these were performed at the T11 level, rather than
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T9, due to the closer proximity to the lumbar CPG and a greater
degree of serotonergic axon reinnervation of the lumbar cord.
Later work showed that with this approach, greater efficacy for
restoring locomotor activity could be obtained when embryonic
serotonergic neuron transplantation after SCI was performed
even closer to the CPG, at the level of lumbo-sacral spinal cord
(Orsal et al., 2002). In addition to using brainstem neurons, Eaton
et al. (2008) used the transplantation of hNT2.19 cells, a human
neuronal cell line differentiated to serotonergic neurons capable
of secreting 5-HT, into the severely contused spinal cord of rats 1
week after SCI to restore serotonergic neurotransmission. When
employed with the combination of environmental enrichment,
a significant improvement in locomotor function was observed,
including reductions in foot exo-rotation and footfall errors on
a gridwalk test. Recently, Sławin´ska et al. (2013) intraspinally
grafted E14 fetal neurons obtained from the medulla, containing
the B1, B2 and B3 serotonergic regions, which constitutes all
the likely sources of descending 5-HT tracts from the caudal
brainstem, after SCI. These fetal neurons were grafted at the
T10/11 vertebra level of adult rats with a complete spinal cord
transection at the T9/10 level and were shown to successfully
restore coordinated plantar stepping and improve intra- and
interlimb coordination. Using pharmacological antagonists, it
was further demonstrated that the transplants mediated their
effects through the activation of 5-HT7 and 5-HT2 receptors
localized to different populations of spinal neurons. Furthermore,
even when these neurons were transplanted at 1 month post-SCI
there was a restoration of coordinated hind limb function evoked
in response to tail stimulation.
Studies employing cellular therapies to replace lost 5-HT pro-
jections to regions below the level of the lesion, particularly to the
CPG, provide a promising means for restoring locomotion after
SCI. At the same time, this approach may be able to overcome
some of the limitations that might be anticipated with a pharma-
cological based strategy, such as a lack of persistent activation of
5-HT receptors as a result of receptor desensitization to prolonged
agonist exposure (Kelly et al., 2008) or side effects associated
with the systemic administration of these drugs (Sławin´ska et al.,
2013). Studies have begun to examine feasible sources of seroton-
ergic neurons that could be used for transplantation paradigms,
particularly the use of induced pluripotent stem cell (IPSC) and
transcription factor cocktails for the generation of these neurons
from either fibroblasts or embryonic stem cells (Shimada et al.,
2012). It remains to be determined whether these cells can be used
to promote improved locomotor output after SCI when employed
in the same experimental paradigms where embryonic brainstem
neurons have demonstrated benefit.
CELL THERAPEUTIC STRATEGIES TO PROMOTE
REGENERATION OF SEROTONERGIC AXONS AND
FUNCTIONAL RECOVERY AFTER SCI
Though there are adaptive mechanisms of endogenous plasticity
within the injured spinal cord and reorganization at the level
of the brain that compensates for the loss of transmission from
multiple descending pathways (Hawthorne et al., 2011; Zörner
et al., 2014), with severe injuries such mechanisms are not able
to reverse paralysis and restore locomotor function without the
use of additional therapeutic interventions. In experimental SCI
paradigms a range of therapeutic approaches have been shown
to limit tissue damage, promote axon growth and plasticity and
improve the degree of functional recovery (Pearse et al., 2004;
Boulenguez and Vinay, 2009). Of the most effective approaches
to improve locomotor outcome after SCI, many have demon-
strated a significant enhancement of growth and regeneration of
descending serotonergic axons caudal to the lesion site (Menei
et al., 1998; Tobias et al., 2003; Pearse et al., 2004; Ramer et al.,
2004; Oatway et al., 2005; Boido et al., 2009; Ghosh et al., 2012;
Hodgetts et al., 2013; Hou et al., 2013; Kanno et al., 2014). It
has been shown in different SCI models, in mice and rats, that
there is some degree of endogenous axon growth/sprouting of
serotonergic axons that occurs (Bregman et al., 1997; Ramón-
Cueto et al., 1998), though the extent of such growth is only short
distance (Bregman et al., 1997) unless an exogenous strategy is
employed. The use of cell therapeutic approaches (Tetzlaff et al.,
2011), such as the implantation of olfactory ensheathing cells
(OECs) in rats with a complete transection SCI and Schwann cell
(SC) bridging, has shown that significant long distance regener-
ation of serotonergic axons across a bridged SCI gap and into
the contiguous caudal cord can be obtained (Ramón-Cueto et al.,
2000); similar findings with OECs have been reported in other
SCI paradigms (Lu et al., 2002; Plant et al., 2003). Though rats
receiving OECs did exhibit modest improvements in hind limb
function, they were unable to recover weight bearing capacity (Lu
et al., 2002) and other neuronal populations, such as those of the
corticospinal tract, failed to regenerate. Recently, Barbour et al.
(2013) transplanted OEG and SCs sub-acutely, at 2 weeks, follow-
ing spinal cord contusion in rat and reported an improvement
in locomotor function that was accompanied by the growth of
supraspinal projections originating from brainstem serotonergic
regions.
The transplantation of genetically modified SCs, to secrete
brain derived neurotrophic factor (BDNF; Menei et al., 1998)
or D15A (Golden et al., 2007; Flora et al., 2013), a bifunctional
neurotrophic molecule capable of activating both TrkB and C
receptors, in transection or contusion SCI, respectively, have been
shown also to promote considerable serotonergic axon regenera-
tion at, and/or beyond, the injury level. Similarly, we have shown
that genetic engineering of SCs, to enhance surface polysialic
acid (PSA), also enhances their ability to support serotonergic
growth across the lesion site and improve locomotor function
when the SCs are transplanted into the contused spinal cord
of rats (Ghosh et al., 2012). Recent work by Hodgetts et al.
(2013) has reported that the transplantation of human mes-
enchymal precursor cells (Stro-1+), obtained from SCI patients
can improve functional recovery and tissue sparing in athymic
nude rats subjected to a 200 kDyne contusion injury at the
vertebral level of T9-T10. The promotion of significant sero-
tonergic axon growth within and surrounding the transplanted
cells was a key anatomical change, although evidence of these
5-HT axons reaching the CPG in the caudal cord was not
investigated.
The use of cell grafts, not only as a source of serotonergic
neurons to provide direct input to the CPG but also as a substrate
for supporting the growth of severed supraspinal serotonergic
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projections across the lesion to reinnervate the CPG, have thus
shown potential for restoring locomotor function after SCI. Fur-
ther enhancement of these approaches with regenerative factors
to encourage greater axon growth into the caudal cord or with
agonists of monoaminergic systems to enhance the functionality
of caudal projections, may be able to provide more robust strate-
gies for the recovery of function after SCI in which the spinal cord
CPG remains intact.
CONCLUSION
The serotonergic pathway works in concert with other
monoaminergic systems in the synaptic control of motoneuron
excitability. 5-HT contributes to the initiation of locomotion and
other rhythmic motor behaviors as well as to the modulation
of synaptic transmission in specific reflex pathways through its
action on presynaptic terminals. Binding of 5-HT to specific
receptor subtypes is responsible for initiating diverse intracellular
signaling cascades that can alter the properties of ligand gated
voltage-sensitive ion channels and produce a subsequent rapid
depolarization of the postsynaptic membrane potential of target
neurons to increase their intrinsic excitability. One of the major
changes that occurs after SCI is the loss of most, if not all, of
the descending monoaminergic input to the spinal cord below
the level of the lesion, particularly to the spinal CPG, resulting
in immediate and persistent locomotor dysfunction. Although
axotomized serotonergic axons have the capacity to undergo
sprouting after SCI, endogenous recovery of locomotor function
is limited.
Substantial progress has been made in our understanding of
the roles of the diverse number of 5-HT receptor subtypes and
how they coordinate with one another and receptor signaling
through other monoaminergic systems to alter motor output
following SCI. The use of either pharmacological or cellular
approaches to modulate the activity of various receptor sub-
types in response to 5-HT or to provide 5-HT input caudal to
the lesion site, respectively, have shown that the restoration of
serotonergic signaling can be an effective means for promot-
ing motoneuron excitability and restoring locomotor function
after SCI. The use of genetic tools to investigate the role of
specific 5-HT receptors in different aspects of motor output or
in understanding the role of regenerating serotonergic axons in
functional efficacy provided by different therapeutic modalities
remains limited and should receive greater attention in future
research.
Approaches to restore function after SCI through targeting
5-HT have shown some degree of success, however, a number
of limitations remain to be resolved and questions answered.
Though the use of 5-HT or specific 5-HT receptor agonists
can stimulate CPG neuronal networks and induce locomotion,
it is not clear whether such an approach can be employed for
sustained functional recovery in light of receptor desensitization
and/or loss of responses to the stimuli over time, a common
phenomenon with GPCR family members. One strategy for
achieving a sustained functional improvement using physiolog-
ical levels of 5-HT could be through cellular therapies, where
serotonergic neurons generated from various sources could be
used to replace lost supraspinal serotonergic projections to the
CPG below the level of SCI. Not only does a cell therapeutic
approach eliminate the risk of side effects associated with sys-
temic administration of high levels of 5-HT receptor agonists
but also allows intraspinal delivery of 5-HT directly to where
it is required after potentially a single intervention. Alterna-
tively, the use of cell transplants, in combination with pro-
regenerative therapies, can be used to bridge the injury site
and provide a substrate for severed serotonergic axons to re-
grow to their original caudal targets. Though the robustness and
applicability of such approaches to a variety of SCI paradigms
and injury levels has not yet been thoroughly investigated and
many cell transplantation strategies to date have failed to pro-
mote the growth of serotonergic axons in significant numbers
beyond the lesion into the contiguous caudal cord let alone
beyond to the lumbar CPG. Another issue with cell therapeutic
approaches is their limited long-term cell survival following trans-
plantation due to the inflammatory environment of the injured
spinal cord and rejection, potentially reducing their effectiveness
in maintaining functional improvements over time. Therefore,
extensive optimization of various cell therapeutic approaches is
currently a priority in the field to maximize their therapeutic
efficacy.
Another promising strategy to induce locomotor function
after SCI in combination with 5-HT or its receptor agonists
involves the activation of spinal locomotor networks via EES and
data so far are encouraging, both in experimental SCI paradigms
and clinically in complete SCI individuals. Similar to the use of
pharmacological approaches alone is whether such a combination
strategy can be implemented for the persistent restoration of
function and whether additional interventions, including cell
transplants, can enhance or prolong the benefits of this strategy.
Further research at the molecular, cellular and functional level to
trigger the necessary sequence of neurological events for complete
restoration of locomotor function after human SCI continues
to remain as a major challenge and a research area of primary
focus. The promotion or facilitation of serotonergic signaling, so
as to enhance motoneuron excitability, stimulate CPG activity and
restore locomotor function, is one direction at the forefront of
research for generating putative interventional approaches for the
treatment of SCI.
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